ImmunoPrecise Antibodies Ltd. financial statements, including revenue, expenses, profit, and loss
The total revenue of IPA for the last quarter is 4.60 M USD, and it's 1.58% higher compared to the previous quarter. The net income of Q3 23 is -2.17 M USD.